Want to join the conversation?
$XRX 2Q15 Q&A: Shannon from Cross Research asked about details on restructuring program? Bob replied, we are heavily focused on services rather than DocTech. We're trying to be little bit careful, but not too quickly relative to optimizing our cost base without being sure that we could maintain and continue to increase delivery qualities.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.